Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Related Citations for PubMed (Select 8486817)

1.

Haloperidol dosing requirements: the contribution of smoking and nonlinear pharmacokinetics.

Perry PJ, Miller DD, Arndt SV, Smith DA, Holman TL.

J Clin Psychopharmacol. 1993 Feb;13(1):46-51.

PMID:
8486817
2.

The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.

Khot V, DeVane CL, Korpi ER, Venable D, Bigelow LB, Wyatt RJ, Kirch DG.

J Clin Psychopharmacol. 1993 Apr;13(2):120-7.

PMID:
8463444
3.

Pharmacokinetic protocol for predicting plasma haloperidol concentrations.

Miller DD, Perry PJ, Kelly MW, Coryell WH, Arndt SV.

J Clin Psychopharmacol. 1990 Jun;10(3):207-12.

PMID:
2376619
4.

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA.

J Clin Psychopharmacol. 2002 Apr;22(2):121-30.

PMID:
11910256
5.

[Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].

Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.

Encephale. 1995 Nov-Dec;21(6):417-24. French.

PMID:
8674466
6.

Haloperidol: therapeutic window in schizophrenia.

Palao DJ, Arauxo A, Brunet M, Bernardo M, Haro JM, Ferrer J, Gonzalez-Monclus E.

J Clin Psychopharmacol. 1994 Oct;14(5):303-10.

PMID:
7806684
7.

A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.

Lin KM, Poland RE, Nuccio I, Matsuda K, Hathuc N, Su TP, Fu P.

Am J Psychiatry. 1989 Oct;146(10):1307-11.

PMID:
2782476
8.

Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.

Chang WH, Jann MW, Chiang TS, Lin HN, Hu WH, Chien CP.

Neuropsychobiology. 1996;33(1):12-6.

PMID:
8821369
9.

Haloperidol plasma levels and acute clinical change in schizophrenia.

Coryell W, Kelly M, Perry PJ, Miller DD.

J Clin Psychopharmacol. 1990 Dec;10(6):397-402.

PMID:
2286709
11.

Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients.

Shimoda K, Someya T, Morita S, Hirokane G, Noguchi T, Yokono A, Shibasaki M, Takahashi S.

Ther Drug Monit. 1999 Jun;21(3):293-6.

PMID:
10365639
12.

Serum haloperidol concentration and clinical response in schizophrenia.

Kirch DG, Bigelow LB, Korpi ER, Wagner RL, Zalcman S, Wyatt RJ.

Schizophr Bull. 1988;14(2):283-9.

13.

The influence of cigarette smoking on haloperidol pharmacokinetics.

Miller DD, Kelly MW, Perry PJ, Coryell WH.

Biol Psychiatry. 1990 Sep 15;28(6):529-31. No abstract available.

PMID:
2223923
14.

Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.

Jibiki I, Kubota T, Fujimoto K, Sakamoto H, Hasegawa M, Furuta H, Yamaguchi N.

Jpn J Psychiatry Neurol. 1993 Sep;47(3):627-9. No abstract available.

PMID:
8301878
15.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
16.

Clinical implications of determination of plasma haloperidol levels.

Santos JL, Cabranes JA, Almoguera I, Ramos JA, Vazquez C, Angeles F.

Acta Psychiatr Scand. 1989 Apr;79(4):348-54.

PMID:
2735205
17.

Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.

Piscitelli SC, Frazier JA, McKenna K, Albus KE, Grothe DR, Gordon CT, Rapoport JL.

J Clin Psychiatry. 1994 Sep;55 Suppl B:94-7.

PMID:
7961584
18.

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

Perry PJ, Bever KA, Arndt S, Combs MD.

Biol Psychiatry. 1998 Oct 15;44(8):733-8.

PMID:
9798077
19.

Serum prolactin as a correlate of clinical response to haloperidol.

Van Putten T, Marder SR, Mintz J.

J Clin Psychopharmacol. 1991 Dec;11(6):357-61.

PMID:
1770154
20.

Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.

Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA.

Biol Psychiatry. 1989 Aug;26(4):381-8.

PMID:
2669981
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk